Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

Status:
Completed

Trial end date:
2015-11-01

Target enrollment:

Participant gender:

An exploratory open label, single treatment trial of anogenital warts with Picato® repeated up to 2 times with two weeks intervals.

Phase 2

LEO Pharma